IRulya Therapeutics, Inc. (IRLA)
39.93
-0.01
(-0.03%)
USD |
NASDAQ |
Nov 20, 16:00
39.93
0.00 (0.00%)
After-Hours: 16:15
IRulya Therapeutics Total Assets (Quarterly) : 106.47M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 106.47M |
| June 30, 2026 | 124.00M |
| March 31, 2026 | 26.62M |
| December 31, 2025 | 93.63M |
| September 30, 2025 | 109.90M |
| June 30, 2025 | 117.21M |
| March 31, 2025 | 107.09M |
| December 31, 2024 | 126.15M |
| September 30, 2024 | 126.52M |
| June 30, 2024 | 134.83M |
| March 31, 2024 | 159.29M |
| December 31, 2023 | 180.20M |
| September 30, 2023 | 85.39M |
| June 30, 2023 | 88.84M |
| March 31, 2023 | 93.32M |
| December 31, 2022 | 104.94M |
| Date | Value |
|---|---|
| September 30, 2022 | 109.78M |
| June 30, 2022 | 117.86M |
| March 31, 2022 | 116.13M |
| December 31, 2021 | 133.23M |
| September 30, 2021 | 147.42M |
| June 30, 2021 | 161.39M |
| March 31, 2021 | 174.52M |
| December 31, 2020 | 189.47M |
| September 30, 2020 | 204.66M |
| June 30, 2020 | 219.21M |
| March 31, 2020 | 231.20M |
| December 31, 2019 | 124.37M |
| September 30, 2019 | 133.41M |
| June 30, 2019 | 143.24M |
| March 31, 2019 | 70.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 462.08M |
| PepGen Inc. | 127.78M |
| Q32 Bio, Inc. | 297.20M |
| Bridgebio Oncology Therapeutics, Inc. | 346.22M |
| Oncolytics Biotech, Inc. | 5.832M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.37M |
| Shareholders Equity (Quarterly) | 78.11M |
| Current Ratio | 14.72 |
| Net Debt Paydown Yield | 11.09% |